The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture Of Basic Pharmaceutical Products
2,000 jobs Number of planned job losses
Announcement Date
2 June 2022
Employment effect (start)
2 June 2022
Foreseen end date
Description
German pharmaceutical company Fresenius has announced that it will cut about 2,000 jobs worldwide.
So far, the company has revealed that 250 positions are expected to be cut in Germany Fresenius Kabi 2022-DE. The layoffs are part of a global efficiency programme and will be carried out at the company’s drug and nutrition division, Fresenius Kabi.
Fresenius provides products and services for dialysis, in hospitals and in outpatient medical care.
Eurofound (2022), Fresenius Kabi , Internal restructuring in World, factsheet number 201683, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/201683.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
